Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Discovery of Anti-PD-L1 Human Domain Antibodies for Cancer Immunotherapy.

PropertyValue
has major subject area list Antineoplastic Agents, Immunological; Colonic Neoplasms; Single-Domain Antibodies
has minor subject area list Animals; Antibodies, Monoclonal; B7-H1 Antigen; Humans; Immunotherapy; Mice; Programmed Cell Death 1 Receptor
information resource reference Liu H, Liu Y, Zhao Z, Li Y, Mustafa B, Chen Z, Barve A, Jain A, Yao X, Li G, Cheng K. Discovery of Anti-PD-L1 Human Domain Antibodies for Cancer Immunotherapy. Front Immunol. 2022; 13:838966.
label Discovery of Anti-PD-L1 Human Domain Antibodies for Cancer Immunotherapy.

Search Criteria
  • Antibodies